Biocon Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	532523	NSE Symbol:	BIOCON	P/E :	0
ISIN Demat:	INE376G01013	Div & Yield %:	0.29	EPS :	0.37
Book Value:	119.85	Market Cap (Rs. Cr.):	52,168.32	Face Value :	5

Date	Headline
09-Jul-25	Biocon schedules board meeting
18-Jun-25	Biocon get facilities rated
09-May-25	Biocon to hold AGM
23-Apr-25	Board of Biocon approves fund raising up to Rs 4,500 cr
21-Apr-25	Biocon to consider fund Raising
05-Apr-25	Board of Biocon approves CP issuance of Rs 600 cr
03-Apr-25	Biocon to table results
02-Apr-25	Biocon to convene board meeting
28-Feb-25	Biocon launches GLP-1 peptide, Liraglutide in the UK
27-Jan-25	Biocon achieves 6 point increase in its S&P Global ESG score to 69 for 2024

Company Snapshot